MediciNova (MNOV)
Develops in-licensed small molecules across neurodegenerative, metabolic, and fibrotic diseases.
$2.91
vs last close+0.00 (+0.17%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
estimated · in 50 days
EPS estimate
−$0.06
Revenue estimate
$50.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.06−$0.06−$0.07−$0.06−$0.06−$0.05−$0.05Pending
Estimate−$0.06−$0.14−$0.07−$0.08−$0.10−$0.06−$0.06−$0.06
Surprise0.0%+57.1%0.0%+25.0%+36.8%+16.7%+21.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported——$134.6K$61.5K$151.0K$187.0K$459.0KPending
Estimate——$123.3K$151.7K—$187.0K$75.0K$50.0K
Surprise——+9.1%−59.5%—0.0%+512.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.12 | — | — |
| Sep 2028 | −$0.11 | — | — |
| Jun 2028 | −$0.10 | — | — |
| Mar 2028 | −$0.11 | — | — |
| Dec 2027 | −$0.16 | — | — |
| Sep 2027 | −$0.12 | — | — |
| Jun 2027 | −$0.10 | — | — |
| Mar 2027 | −$0.08 | — | — |
| Dec 2026 | −$0.08 | — | — |
| Nov 2026 | −$0.06 | — | — |
| Aug 2026 | −$0.06 | −$0.05 | +21.0% |
| May 2026 | −$0.06 | −$0.05 | +16.7% |
| Feb 2026 | −$0.10 | −$0.06 | +36.8% |
| Nov 2025 | −$0.08 | −$0.06 | +25.0% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.12 | — | — | $81.0K | — | — | — |
| Sep 2028 | −$0.11 | — | — | $96.4K | — | — | — |
| Jun 2028 | −$0.10 | — | — | $114.6K | — | — | — |
| Mar 2028 | −$0.11 | — | — | $136.3K | — | — | — |
| Dec 2027 | −$0.16 | — | — | $162.1K | — | — | — |
| Sep 2027 | −$0.12 | — | — | $192.7K | — | — | — |
| Jun 2027 | −$0.10 | — | — | $229.2K | — | — | — |
| Mar 2027 | −$0.08 | — | — | $272.6K | — | — | — |
| Dec 2026 | −$0.08 | — | — | $33.3K | — | — | — |
| Nov 12, 2026 | −$0.06 | — | — | $50.0K | — | — | — |
| Aug 13, 2026 | −$0.06 | −$0.05 | +21.0% | $75.0K | $459.0K | +512.0% | 0.0% |
| May 15, 2026 | −$0.06 | −$0.05 | +16.7% | $187.0K | $187.0K | 0.0% | +0.7% |
| Feb 20, 2026 | −$0.10 | −$0.06 | +36.8% | — | $151.0K | — | −0.7% |
| Nov 13, 2025 | −$0.08 | −$0.06 | +25.0% | $151.7K | $61.5K | −59.5% | +0.7% |
| Aug 14, 2025 | |||||||
| May 14, 2025 | |||||||
| Feb 19, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 10, 2024 | |||||||
| Feb 15, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Feb 16, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Feb 17, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Feb 18, 2021 | |||||||
| Oct 26, 2020 | |||||||
| Jul 28, 2020 | |||||||
| Apr 23, 2020 | |||||||
| Feb 13, 2020 | |||||||
| Oct 25, 2019 | |||||||
| Jul 25, 2019 | |||||||
| Apr 25, 2019 | |||||||
| Feb 13, 2019 | |||||||
| Oct 25, 2018 | |||||||
| Jul 23, 2018 | |||||||
| Apr 25, 2018 | |||||||
| Feb 13, 2018 | |||||||
| Oct 23, 2017 | |||||||
| Jul 26, 2017 | |||||||
| Apr 26, 2017 | |||||||
| Feb 14, 2017 | |||||||
| Oct 25, 2016 | |||||||
| Jul 26, 2016 | |||||||
| Apr 27, 2016 | |||||||
| Feb 25, 2016 | |||||||
| Oct 29, 2015 | |||||||
| Jul 30, 2015 |